Literature DB >> 12895669

Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function.

Melanie-Jayne R Howes1, Peter J Houghton.   

Abstract

In traditional practices of Ayurvedic and Chinese medicine, numerous plants have been used to treat cognitive disorders, including neurodegenerative diseases such as Alzheimer's disease (AD). An ethnopharmacological approach has provided leads to identifying potential new drugs from plant sources, including those for cognitive disorders. Many drugs currently available in Western medicine were originally isolated from plants, or are derived from templates of compounds isolated from plants. Some anticholinesterase (anti-ChE) alkaloids isolated from plants have been investigated for their potential in the treatment of AD, and are now in clinical use. Galantamine, isolated from several plants including Lycoris radiata Herb., which was used in traditional Chinese medicine (TCM), is licensed in the United Kingdom for the treatment of mild to moderate AD. Various other plant species have shown pharmacological activities relevant to the treatment of cognitive disorders, indicating potential for therapeutic use in disorders such as AD. This article reviews some of the plants and their active constituents that have been used in traditional Ayurvedic medicine and TCM for their reputed cognitive-enhancing or antiageing effects. Plants and their constituents with pharmacological activities that may be relevant for the treatment of cognitive disorders, including enhancement of cholinergic function in the central nervous system (CNS), anti-inflammatory and antioxidant activities, are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12895669     DOI: 10.1016/s0091-3057(03)00128-x

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  75 in total

Review 1.  The role of phytochemicals in the treatment and prevention of dementia.

Authors:  Melanie-Jayne R Howes; Elaine Perry
Journal:  Drugs Aging       Date:  2011-06-01       Impact factor: 3.923

Review 2.  Natural products as a source of Alzheimer's drug leads.

Authors:  Philip Williams; Analia Sorribas; Melanie-Jayne R Howes
Journal:  Nat Prod Rep       Date:  2010-11-12       Impact factor: 13.423

3.  Studies of natural products on treating neurological disorders in China.

Authors:  Hai Yan Zhang; Xi Can Tang
Journal:  Cell Mol Neurobiol       Date:  2007-11-28       Impact factor: 5.046

4.  Scutellarin protects against Aβ-induced learning and memory deficits in rats: involvement of nicotinic acetylcholine receptors and cholinesterase.

Authors:  Li-li Guo; Zhi-zhong Guan; Yong-lin Wang
Journal:  Acta Pharmacol Sin       Date:  2011-10-10       Impact factor: 6.150

5.  Antioxidant and anti-acetylcholinesterase activities of extracts and secondary metabolites from Acacia cyanophylla.

Authors:  Lotfi Ghribia; Hatem Ghouilaa; Amel Omrib; Malek Besbesb; Hichem Ben Janneta
Journal:  Asian Pac J Trop Biomed       Date:  2014-05

6.  Bacopa monnieri prevents colchicine-induced dementia by anti-inflammatory action.

Authors:  Neetu Saini; Devinder Singh; Rajat Sandhir
Journal:  Metab Brain Dis       Date:  2019-01-02       Impact factor: 3.584

Review 7.  Regenerative medicine in Alzheimer's disease.

Authors:  Kevin M Felsenstein; Kate M Candelario; Dennis A Steindler; David R Borchelt
Journal:  Transl Res       Date:  2013-11-08       Impact factor: 7.012

8.  Biological Evaluation of Polyherbal Ayurvedic Cardiotonic Preparation "Mahamrutyunjaya rasa".

Authors:  Pallavi D Rai; Sadhana J Rajput
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-02       Impact factor: 2.629

9.  Pharmacokinetics and dopamine/acetylcholine releasing effects of ginsenoside Re in hippocampus and mPFC of freely moving rats.

Authors:  Jing Shi; Wei Xue; Wen-jie Zhao; Ke-xin Li
Journal:  Acta Pharmacol Sin       Date:  2012-12-03       Impact factor: 6.150

10.  Modified Wendan Decoction can Attenuate Neurotoxic Action Associated with Alzheimer's Disease.

Authors:  Ping Liu; Lei Zhao; Shu-Ling Zhang; Ji-Zhou Xiang
Journal:  Evid Based Complement Alternat Med       Date:  2007-10-10       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.